798
Participants
Start Date
January 1, 2011
Primary Completion Date
May 31, 2020
Study Completion Date
December 31, 2030
smoking and alcohol assumption
documenting the change of smoking and drinking status during the follow-up period
genetic sequencing
sequencing the susceptibility genes for CP, including serine protease inhibitor Kazal type 1, cationic trypsinogen, cystic fibrosis transmembrane conductance regulator, chymotrypsin C, etc.
Changhai Hospital
OTHER